CHAT and dementia: AF64A, a cholinergic toxin widely used in screening drugs for dementia treatment development, is internalized only into cholinergic neurons by the high-affinity choline transport system, causing alterations in the mRNA expression and activity of choline acetyltransferase (ChAT).